Vermillion to Report Second Quarter 2017 Financial Results and Host Investor Conference Call on August 8th


AUSTIN, Texas, July 27, 2017 — Vermillion, Inc. (Nasdaq: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that it will report its second quarter 2017 financial results on Tuesday, August 8, 2017, followed by an investor conference call and webcast at 4:30 p.m. Eastern Time.

Vermillion to Report Second Quarter 2017 Financial Results

Tuesday, August 8th @ 4:30pm Eastern Time

Domestic:                   888-437-9274

International:             719-325-2437

Conference ID:           8515049



Replays, Available through August 22nd

Domestic:                   844-512-2921

International:             412-317-6671

Replay PIN:                8515049


About Vermillion

Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion, along with its prestigious scientific collaborators, discovers, develops, and delivers innovative diagnostic and technology tools that help women with serious diseases.


Investor Relations Contact:

Michael Wood

LifeSci Advisors LLC